Press releases
- Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit
- Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
- Evolus Reports First Quarter 2024 Results and Provides Business Update
- Evolus to Report First Quarter Financial Results on May 7, 2024
- Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
- Evolus to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Evolus Announces Pricing of $50.0 Million Underwritten Offering of Common Stock
- Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
- Evolus Announces Results from European Head-to-Head Filler Trial
More ▼
Key statistics
On Friday, Evolus Inc (0K16:LSE) closed at 13.30, -13.50% below its 52-week high of 15.38, set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 13.30 |
Average volume | 404.89 |
---|---|
Shares outstanding | 62.61m |
Free float | 48.93m |
P/E (TTM) | -- |
Market cap | 850.88m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 20 minutes, as of May 17 2024 16:15 BST.
More ▼